The duty to disclose adverse clinical trial results.
Participants in some clinical trials are at risk of being harmed and sometimes are seriously harmed as a result of not being provided with available, relevant risk information. We argue that this situation is unacceptable and that there is a moral duty to disclose all adverse clinical trial results...
Main Authors: | Liao, S, Sheehan, M, Clarke, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Disclosing clinical trial results: publicity, significance and independence.
by: Liao, S, et al.
Published: (2009) -
Randomization should be disclosed to potential research subjects.
by: Binik, A, et al.
Published: (2013) -
Comparative Study of Securities issuer's affirmative duty to disclose information
in Iranian and American Law
by: Morteza Shahidi, et al.
Published: (2020-04-01) -
Press releases for Phase 2 clinical trial topline results: Have the objective pre-specified efficacy results been disclosed?
by: Zheng Su, et al.
Published: (2016-12-01) -
Why Wait? The Ethics of Disclosing HIV Screening Results
by: Zain Aryanpour MD, et al.
Published: (2023-05-01)